APYX MEDICAL CORPORATI

Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™

13 May 2025 05:00:01 By Nasdaq GlobeNewswire

Apyx Medical Corporation Reports First Quarter 2025 Financial Results

08 May 2025 04:00:01 By Nasdaq GlobeNewswire

Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures

29 Apr 2025 05:00:01 By Nasdaq GlobeNewswire

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

24 Apr 2025 05:45:51 By Nasdaq GlobeNewswire

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

13 Mar 2025 04:00:01 By Nasdaq GlobeNewswire

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025

27 Feb 2025 05:00:00 By Nasdaq GlobeNewswire

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results

13 Jan 2025 05:00:01 By Nasdaq GlobeNewswire

Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™

06 Jan 2025 05:00:00 By Nasdaq GlobeNewswire

Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference

27 Nov 2024 05:00:00 By Nasdaq GlobeNewswire

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

12 Nov 2024 13:05:00 By Nasdaq GlobeNewswire

Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

08 Nov 2024 04:05:00 By Nasdaq GlobeNewswire

Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

08 Nov 2024 04:00:00 By Nasdaq GlobeNewswire

Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

25 Oct 2024 05:00:00 By Nasdaq GlobeNewswire